Cim Investment Management Inc Emergent Bio Solutions Inc. Transaction History

Cim Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$36.48 - $52.22 $172,951 - $247,575	-4,741 Closed	0 $0
Q4 2021 May 19, 2022	SELL	$33.11 - $55.01 $156,974 - $260,802	-4,741 Reduced 50.0%	4,741 $206,000
Q4 2021 Feb 02, 2022	BUY	$33.11 - $55.01 $156,974 - $260,802	4,741 Added 100.0%	9,482 $443,000
Q1 2021 May 20, 2021	SELL	$86.23 - $125.19 $24,403 - $35,428	-283 Reduced 5.63%	4,741 $440,000
Q4 2020 Feb 17, 2021	BUY	$79.17 - $111.47 $397,750 - $560,025	5,024 New	5,024 $450,000
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $316,827 - $521,947	-3,868 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $210,148 - $346,263	3,868 New	3,868 $306,000

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.